Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-25-008460
Filing Date
2025-02-27
Accepted
2025-02-27 08:15:43
Documents
95
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 1818812
2 ex4-7.htm EX-4.7 67833
3 ex19.htm EX-19 5420
4 ex21-1.htm EX-21.1 4193
5 ex23-1.htm EX-23.1 5175
6 ex31-1.htm EX-31.1 17851
7 ex31-2.htm EX-31.2 17668
8 ex32-1.htm EX-32.1 8238
9 ex32-2.htm EX-32.2 8242
10 ex19_001.jpg GRAPHIC 1029348
11 ex19_002.jpg GRAPHIC 1164577
12 ex19_003.jpg GRAPHIC 879613
13 ex19_004.jpg GRAPHIC 1317323
14 ex19_005.jpg GRAPHIC 1311250
15 ex19_006.jpg GRAPHIC 574340
  Complete submission text file 0001493152-25-008460.txt   15956084

Data Files

Seq Description Document Type Size
16 XBRL SCHEMA FILE imnn-20241231.xsd EX-101.SCH 50002
17 XBRL CALCULATION FILE imnn-20241231_cal.xml EX-101.CAL 70939
18 XBRL DEFINITION FILE imnn-20241231_def.xml EX-101.DEF 186756
19 XBRL LABEL FILE imnn-20241231_lab.xml EX-101.LAB 465950
20 XBRL PRESENTATION FILE imnn-20241231_pre.xml EX-101.PRE 363751
98 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 866347
Mailing Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648
Business Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648 (609) 896-9100
Imunon, Inc. (Filer) CIK: 0000749647 (see all company filings)

EIN.: 521256615 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-15911 | Film No.: 25673155
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)